Camila F. Almeida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Camila F. Almeida has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Mariz Vainzof
Human Genome and Stem Cells Research Center, Institute of Biosciences, University of São Paulo, São Paulo 05508-090, SP, Brazil
2 shared publications Alex Brinkman
Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA
1 shared publicationAlice Rannou
Nantes Université, CHU de Nantes, INSERM, TaRGeT-Translational Research in Gene Therapy, UMR 1089, F-44200, Nantes, France
1 shared publication- Anne Bigot
Sorbonne Université, Inserm, Institut de Myologie, Centre de Recherche en Myologie, Paris, France
1 shared publication Chaitrali Atre
Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA
1 shared publicationCourtney S. Young
MyoGene Bio, 7098 Miratech Dr Suite 120 San Diego, 92121, USA
1 shared publication
Latest Publications
- Open Access
- 25 August 2026
- Published by Elsevier in Neuromuscular Disorders
- Vol. 67, 107396
Histological, functional, and behavioral comparison of three Duchenne muscular dystrophy mouse models
- 25 August 2026
- Published by Elsevier in Neuromuscular Disorders
- Vol. 67, 107396
Open AccessHistological, functional, and behavioral comparison of three Duchenne muscular dystrophy mouse models
- 14 March 2021
- Published by Wiley in The FASEB Journal
- Vol. 35 (4) , e21346
Satellite cells deficiency and defective regeneration in dynamin 2‐related centronuclear myopathy
Dynamin 2 (DNM2) is a ubiquitously expressed protein involved in many functions related to trafficking and remodeling of membranes and cytoskeleton dynamics. Mutations in the DNM2 gene cause the autosomal dominant centronuclear myopathy (AD‐CNM), characterized mainly by muscle weakness and central nuclei. Several defects have been identified in the KI‐ Dnm2 R465W/+ mouse model of the disease to explain the muscle phenotype, including reduction of the satellite cell pool in muscle, but the functional consequences of this depletion have not been characterized until now. Satellite cells (SC) are the main source for muscle growth and regeneration of mature tissue. Here, we investigated muscle regeneration in the KI‐ Dnm2 R465W/+ mouse model for AD‐CNM. We found a reduced number of Pax7‐positive SCs, which were also less activated after induced muscle injury. The muscles of the KI‐ Dnm2 R465W/+ mouse regenerated more slowly and less efficiently than wild‐type ones, formed fewer new myofibers, and did not recover its normal mass 15 days after injury. Altogether, our data provide evidence that the muscle regeneration is impaired in the KI‐ Dnm2 R465W/+ mouse and contribute with one more layer to the comprehension of the disease, by identifying a new pathomechanism linked to DNM2 mutations which may be involved in the muscle‐specific impact occurring in AD‐CNM.
- 14 March 2021
- Published by Wiley in The FASEB Journal
- Vol. 35 (4) , e21346
Satellite cells deficiency and defective regeneration in dynamin 2‐related centronuclear myopathy
Dynamin 2 (DNM2) is a ubiquitously expressed protein involved in many functions related to trafficking and remodeling of membranes and cytoskeleton dynamics. Mutations in the DNM2 gene cause the autosomal dominant centronuclear myopathy (AD‐CNM), characterized mainly by muscle weakness and central nuclei. Several defects have been identified in the KI‐ Dnm2 R465W/+ mouse model of the disease to explain the muscle phenotype, including reduction of the satellite cell pool in muscle, but the functional consequences of this depletion have not been characterized until now. Satellite cells (SC) are the main source for muscle growth and regeneration of mature tissue. Here, we investigated muscle regeneration in the KI‐ Dnm2 R465W/+ mouse model for AD‐CNM. We found a reduced number of Pax7‐positive SCs, which were also less activated after induced muscle injury. The muscles of the KI‐ Dnm2 R465W/+ mouse regenerated more slowly and less efficiently than wild‐type ones, formed fewer new myofibers, and did not recover its normal mass 15 days after injury. Altogether, our data provide evidence that the muscle regeneration is impaired in the KI‐ Dnm2 R465W/+ mouse and contribute with one more layer to the comprehension of the disease, by identifying a new pathomechanism linked to DNM2 mutations which may be involved in the muscle‐specific impact occurring in AD‐CNM.
- Open Access
- 10 January 2020
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 13 (2)
Altered in vitro muscle differentiation in X-linked myopathy with excessive autophagy
X-linked myopathy with excessive autophagy (XMEA) is a genetic disease associated with weakness of the proximal muscles. It is caused by mutations in the VMA21 gene, coding for a chaperone that functions in the vacuolar ATPase (v-ATPase) assembly. Mutations associated with lower content of assembled v-ATPases lead to an increase in lysosomal pH, culminating in partial blockage of macroautophagy, with accumulation of vacuoles of undigested content. Here, we studied a 5-year-old boy affected by XMEA, caused by a small indel in the VMA21 gene. Detection of sarcoplasmic Lc3 (also known as MAP1LC3B)-positive vacuoles in his muscle biopsy confirmed an autophagy defect. To understand how autophagy is regulated in XMEA myogenesis, we used patient-derived muscle cells to evaluate autophagy during in vitro muscle differentiation. An increase in lysosomal pH was observed in the patient's cells, compatible with predicted functional defect of his mutation. Additionally, there was an increase in autophagic flux in XMEA myotubes. Interestingly, we observed that differentiation of XMEA myoblasts was altered, with increased myotube formation observed through a higher fusion index, which was not dependent on lysosomal acidification. Moreover, no variation in the expression of myogenic factors nor the presence of regenerating fibers in the patient's muscle were observed. Myoblast fusion is a tightly regulated process; therefore, the uncontrolled fusion of XMEA myoblasts might generate cells that are not as functional as normal muscle cells. Our data provide new evidence on the reason for predominant muscle involvement in the context of the XMEA phenotype. This article has an associated First Person interview with the first author of the paper.
- 10 January 2020
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 13 (2)
Open AccessAltered in vitro muscle differentiation in X-linked myopathy with excessive autophagy
X-linked myopathy with excessive autophagy (XMEA) is a genetic disease associated with weakness of the proximal muscles. It is caused by mutations in the VMA21 gene, coding for a chaperone that functions in the vacuolar ATPase (v-ATPase) assembly. Mutations associated with lower content of assembled v-ATPases lead to an increase in lysosomal pH, culminating in partial blockage of macroautophagy, with accumulation of vacuoles of undigested content. Here, we studied a 5-year-old boy affected by XMEA, caused by a small indel in the VMA21 gene. Detection of sarcoplasmic Lc3 (also known as MAP1LC3B)-positive vacuoles in his muscle biopsy confirmed an autophagy defect. To understand how autophagy is regulated in XMEA myogenesis, we used patient-derived muscle cells to evaluate autophagy during in vitro muscle differentiation. An increase in lysosomal pH was observed in the patient's cells, compatible with predicted functional defect of his mutation. Additionally, there was an increase in autophagic flux in XMEA myotubes. Interestingly, we observed that differentiation of XMEA myoblasts was altered, with increased myotube formation observed through a higher fusion index, which was not dependent on lysosomal acidification. Moreover, no variation in the expression of myogenic factors nor the presence of regenerating fibers in the patient's muscle were observed. Myoblast fusion is a tightly regulated process; therefore, the uncontrolled fusion of XMEA myoblasts might generate cells that are not as functional as normal muscle cells. Our data provide new evidence on the reason for predominant muscle involvement in the context of the XMEA phenotype. This article has an associated First Person interview with the first author of the paper.